Oncology + Eternal = Oncternal

We are committed to advancing novel oncology therapies for the treatment of patients with cancers that have critical unmet medical need. Our scientific approach focuses on promising, yet untapped biological pathways implicated in cancer generation or progression.

Our Pipeline

Oncology + Eternal = Oncternal

We are committed to advancing novel oncology therapies for the treatment of patients with cancers that have critical unmet medical need. Our scientific approach focuses on promising, yet untapped biological pathways implicated in cancer generation or progression.

Our Pipeline

Oncology + Eternal = Oncternal

We are committed to advancing novel oncology therapies for the treatment of patients with cancers that have critical unmet medical need. Our scientific approach focuses on promising, yet untapped biological pathways implicated in cancer generation or progression.

Our Pipeline

Welcome to Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments to treat hematological malignancies and prostate cancer across multiple modalities.

About Our Science
Meet Our Team

RECENT NEWS

On September 12, 2024, Oncternal announced it was discontinuing its clinical trials and exploring strategic alternatives.